Jonathan C. Roberts - Jan 27, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP & Chief Operating Officer
Signature: Jonathan C. Roberts
Stock symbol: CVS
Transactions as of: Jan 27, 2022
Transactions value $: -$358,846
Form type: 4
Date filed: 1/28/2022, 03:58 PM
Previous filing: Nov 5, 2021
Next filing: Feb 23, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock	Options Exercise	$7M	+68.5K	+63.93%	$102.26	176K	Jan 27, 2022	Direct
transaction	CVS	Common Stock	Sale	-$7.36M	-68.5K	-39%	$107.50	107K	Jan 27, 2022	Direct	F1
holding	CVS	Common Stock						34.7K	Jan 27, 2022	By GRAT
holding	CVS	Common Stock (restricted)						12.8K	Jan 27, 2022	Direct
holding	CVS	ESOP Common Stock						6.05K	Jan 27, 2022	By ESOP

Showing 1 to 5 of 5 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Options Exercise	$0	-68.5K	-100%	$0.00^*	0	Jan 27, 2022	Common Stock	68.5K	$102.26	Direct	F2
holding	CVS	Phantom Stock Credits						1.42K	Jan 27, 2022	Common Stock	1.42K	$1.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All sales were effected pursuant to a Rule 10b5-1 plan.
F2	Option became exercisable in four equal annual installments, commencing 4/1/2016.
F3	Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.